Pan-intestinal Capsule Endoscopy Versus Colonoscopy in Iron Deficiency Anemia or Overt GI Bleeding
1 other identifier
interventional
100
1 country
1
Brief Summary
The authors hypothesize that in patients with iron deficiency anemia or gastrointestinal bleeding, pan-intestinal capsule endoscopy is a safe and well tolerated procedure that may improve diagnostic yield comparatively to the current standard invasive colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 19, 2020
CompletedFirst Submitted
Initial submission to the registry
February 20, 2021
CompletedFirst Posted
Study publicly available on registry
March 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2023
CompletedSeptember 22, 2023
September 1, 2023
2.3 years
February 20, 2021
September 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with at least one potentially bleeding lesion detected in small bowel and/or colon
Potentially bleeding lesions include tumors, angiectasias, erosions, ulcers, diverticula or active bleeding
2 weeks
Secondary Outcomes (2)
Safety: number of participants with any procedure-related adverse events
2 weeks
Patient's preference: number of participants preferring capsule endoscopy or colonoscopy
2 weeks
Other Outcomes (3)
Quality of bowel preparation at capsule endoscopy (small bowel)
2 weeks
Quality of bowel preparation at capsule endoscopy (colon)
2 weeks
Quality of bowel preparation at colonoscopy
2 weeks
Study Arms (2)
Pan-intestinal capsule endoscopy
EXPERIMENTALPillCam Crohn's capsule protocol
Conventional colonoscopy
ACTIVE COMPARATORSame-day colonoscopy under propofol sedation
Interventions
Patients with iron deficiency anemia or overt GI bleeding with non-diagnostic upper GI endoscopy will be submitted to same-day pan-intestinal capsule endoscopy using PillCam Crohn's Capsule (Medtronic) followed by conventional colonoscopy under propofol sedation
Eligibility Criteria
You may qualify if:
- Patients from external consultation, hospital ward or urgency department, with suspected GI bleeding presenting in the occult form as IDA (Hb \<12.0 g/dL in female gender or \<13.0 g/dL in male gender) and/or overt GI bleeding presenting as melaena and/or haematochezia, and with prior non-diagnostic upper GI endoscopy (esophagogastroduodenoscopy, EGD)
You may not qualify if:
- Lack of informed consent
- Suspected lesions at index EGD that could justify the anemia or digestive bleeding
- Known history of gastroparesis or bowel dysmotility
- Known or suspected intestinal stricture
- Female patients with potential gynaecological source of bleeding causative of the clinical condition
- Patients with severe malnutrition
- Patients unable to walk at least for short periods and/or with neurological and/or psychiatric condition potentially favouring protocol deviations
- Allergy or contra-indications to any of the drugs or products used in the study
- Pregnancy or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unidade Local de Saúde do Alto Ave, EPElead
- Medtroniccollaborator
Study Sites (1)
Gastroenterology Department, Hospital da Senhora da Oliveira
Guimarães, 4835-044, Portugal
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bruno Rosa, MD
Gastroenterology Department, Hospital da Senhora da Oliveira - Guimarães, Portugal
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Masking Details
- The capsule endoscopy reader will be independent from the physicians performing the conventional colonoscopies, and all investigators will be blinded to each other's findings and reports. Capsule endoscopy and colonoscopy findings will be compared and in case of disagreement it will be discussed until a consensus is reached, if necessary, with the intervention of an independent third reader, experienced in both techniques and not involved in the primary reading of any of the examinations.
- Purpose
- DIAGNOSTIC
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 20, 2021
First Posted
March 4, 2021
Study Start
June 19, 2020
Primary Completion
September 20, 2022
Study Completion
January 31, 2023
Last Updated
September 22, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share